Zoomed Image
  • Travocort Cream 15g

Travocort Cream 15g

TRAVOCORT contains isoconazole nitrate 10 mg and diflucortolone valerate 1 mg in an easy-to-remove low fat base oil water emulsion. Isoconazole nitrate is for use in the treatment of superficial fungal diseases of the skin. It is effective against dermatophytes and yeasts, yeast-like fungi and moulds, as well as against the causative organism of tinea versicolor and that of erythrasma. Diflucortolone valerate is a potent fluorinated corticosteroid with vasoconstrictive properties and suppresses inflammation in inflammatory and allergic skin conditions. It reverses capillary dilatation, intercellular oedema and tissue infiltration whilst capillary proliferation is suppressed. Fungal infections of hairless and hairy skin, e.g. in the region of the hands, the interdigital spaces of the
feet, and in the inguinal and genital regions. Because of the addition of diflucortolone valerate, TRAVOCORT is indicated for the initial or intermediate treatment of those fungal diseases which are accompanied by highly inflammatory or eczematous skin conditions.
How to use
Unless otherwise instructed, TRAVOCORT should be applied twice daily to the diseased areas of skin. In infections of the interdigital spaces it is often advisable to place a strip of gauze smeared with TRAVOCORT between the toes or fingers. The treatment with TRAVOCORT must be terminated after regression of the inflammatory or eczematous skin condition and the therapy continued or followed up with the isoconazole nitrate preparation without corticoid additive. This applies in particular for use in inguinal and genital regions. If a secondary microbial skin infection is present suitable concomitant anti-microbial therapy should be instituted. If fungal infections are present, a topically active antimycotic should be applied.
CONTRAINDICATIONS: -Hypersensitivity to the active substances or to any of the excipients. Tuberculous or syphilitic processes in the area to be treated; virus diseases (e.g. varicella, herpes zoster), rosacea, perioral dermatitis and postvaccination skin reactions in the area to be treated.